Evaluation of pharmacokinetic/pharmacodynamic model-based optimized combination regimens against multidrug-resistant Pseudomonas aeruginosa in a murine …

R Yadav, JB Bulitta, J Wang, RL Nation… - Antimicrobial agents …, 2017 - Am Soc Microbiol
We previously optimized imipenem and tobramycin combination regimens against a double-
resistant clinical Pseudomonas aeruginosa isolate by using in vitro infection models …

Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model

YQ Xiong, J Caillon, MF Kergueris… - Antimicrobial agents …, 1997 - Am Soc Microbiol
Adaptive resistance following the first exposure to aminoglycosides is a recently described
in vitro phenomenon in Pseudomonas aeruginosa and other aerobic gram-negative bacilli …

In vitro antimicrobial synergy testing of extensively drug-resistant clinical isolates at an organ transplant center in Nepal

R Karki, S Lamichhane, BB Basnet… - Infection and Drug …, 2021 - Taylor & Francis
Purpose Inappropriate use of broad-spectrum antibiotics contributes to the emergence of
multidrug-resistant (MDR) bacteria. Finding novel antimicrobial agents and strategies based …

The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model

S Gudmundsson, S Einarsson… - Journal of …, 1993 - academic.oup.com
The post-antibiotic effect (PAE) may allow for more widely spaced dosing of antibiotics than
is currently employed without loss of efficacy. Antimicrobial combinations are widely used in …

In vivo activity of interferon-γ in combination with amphotericin B in the treatment of experimental cryptococcosis

V Joly, L Saint-Julien, C Carbon… - Journal of infectious …, 1994 - academic.oup.com
The effect of recombinant interferon-ã (rIFN-ã) on Cryptococcus neoformans infection was
investigated in vivo. BALB/c mice were injected intravenously with 2'd7 106 C. neoformans …

Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3- or OXA-48-producing Escherichia coli

M Berleur, F Guérin, L Massias, F Chau… - Journal of …, 2018 - academic.oup.com
Background Alternative therapeutic regimens are urgently needed against carbapenemase-
producing Enterobacteriaceae. Fosfomycin often remains active against KPC and OXA-48 …

Using host-mimicking conditions and a murine cutaneous abscess model to identify synergistic antibiotic combinations effective against Pseudomonas aeruginosa

N Lyons, W Wu, Y Jin, IL Lamont… - Frontiers in Cellular and …, 2024 - frontiersin.org
Antibiotic drug combination therapy is critical for the successful treatment of infections
caused by multidrug resistant pathogens. We investigated the efficacy of β-lactam and β …

[PDF][PDF] Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis

AC Cremieux, C Carbon - Antimicrobial agents and …, 1992 - Am Soc Microbiol
Bacterial endocarditis is a deep, difficult-to-cure infection. Although most organisms are
highly susceptible to many antibiotics, therapy must be maintained for weeks in order to …

Treatment and prevention of nosocomial pneumonia

E Bergogne-Berezin - Chest, 1995 - journal.chestnet.org
Nosocomial pneumonia, which is defined as a lower respiratory tract infection neither
present nor incubating on admission, is the second most frequent manifestation of hospital …

Editorial response: meta-analyses are no longer required for determining the efficacy of single daily dosing of aminoglycosides

DN Gilbert - Clinical infectious diseases, 1997 - JSTOR
Investigators conducting clinical trials may have trouble rep-licating in ill patients results
obtained in tightly controlled models of efficacy and toxicity that use healthy animals [1] …